Vertex Pharmaceutica
VRTX
Delayed Nasdaq - 12/11 09:09:04 pm
140.95USD
-1.85%
Upcoming events
01/31/18
FY 2017 Earnings Release (Projected)
Past Events
11/07/17 | 04:35pmCredit Suisse Health Care Conference
11/03/17 | 03:35pmNorth American Cystic Fibrosis Conference
10/25/17 | 10:30pmQ3 2017 Earnings Call
10/25/17 | 10:01pmQ3 2017 Earnings Release
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
1 701
1 696
0,30%

2 372
Operating income (EBITDA)
Million $
Released
Forecast
Spread
350
329
6,2%

556
Operating profit (EBIT)
Million $
Released
Forecast
Spread
288
242
19%

537
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-112
-133
16%

256
EPS
 $
Released
Forecast
Spread
-0,46
-0,46
-0,94%

0,94
Announcement Date01/25/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
578
520
11%

596
Operating income (EBITDA)
Million $
Released
Forecast
Spread
160
63,5
153%

71,1
Operating profit (EBIT)
Million $
Released
Forecast
Spread
145
90,1
61%

150
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-103
-104
1,0%

73,8
EPS
 $
Released
Forecast
Spread
-0,41
-0,44
6,6%

0,27
Announcement Date10/25/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise